You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cardiovascular conditions
  5. Acute coronary syndromes

Optowire for measuring fractional flow reserve

  • Medtech innovation briefing
  • Reference number: MIB199
  • Published:  03 December 2019

Download (PDF)
  • Overview
  • Summary
  • The technology
  • Regulatory information
  • Equality considerations
  • Clinical and technical evidence
  • Specialist commentator comments
  • Specialist commentators
  • Development of this briefing

Regulatory information

Opsens Optowire is CE marked as a class III medical device. It received its CE mark in 2014.


Next page Equality considerations Previous page The technology
Back to top